Impairment of the upper extremity after CVI
Conditions
Interventions
Group 1: grip strength measurement
Sponsors
Klinik für Neurologie und Neurorehabilitation
Eligibility
Sex/Gender
All
Age
18 Years to 95 Years
Inclusion criteria
Inclusion criteria: patients after stroke, primary event < 24 months, no additional diagnosis, which the treatment for improving the hand and arm function is negatively influenced. age =18 A degree of active arm/ Hand function (Chedoke- McMaster Stroke Assessment: handstadium: 2-7) passive range of Motion shoulder: Flexion/ABD= 60° elbow: Deficit of extension = 30° hand wrist: extension = 0° fingerextension: ability to open the hand half way ability to communicate in German language plus enough speech comprehension and appropriate cognitive abilities to implement simple tasks written informed consent
Exclusion criteria
Exclusion criteria: severve sensory loss (NIH-Stroke Scale: sensibility(arm) = 2 points (no surface and deep sensibility) shoulder pain (Chedoke shoulder – pain = 5) severve/ global aphasia epilepsy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Investigating the intrater and interater - reliability of the Manovo®Power measuring Hand strength. the Manovo®Power is a tool used to measure Hand strength. The Biometrics E- Link Hand grip Dynamometer is a measuring tool to measure Hand strength. The Hand strenght will be measured with the Manovo®Power on 2 days in the morning with an interval of 2-3 days inbetween (example: Mo-We-Fr or We-Fr-Mo) The Hand strenght will also be measured with the Biometrics E- Link Hand grip Dynamometer on 2 days in the afternoon with an interval of 2-3 days inbetween (example: Mo-We-Fr or We-Fr-Mo) | — |
Secondary
| Measure | Time frame |
|---|---|
| Investigating the correlation between the Manovo®Power assessment and Biometrics E-Link Hand grip Dynamometer. Therby, a third measurement will be performed. Evaluation on patients satisfaction and practicality from the therapist's point of view. The questionnaire will be specially develped to evaluate the patient's satisfaction, respectively the practcality of use. | — |
Countries
Switzerland
Contacts
Public ContactStefan Ortmann
Klinik für Neurologie und Neurorehabilitation
Outcome results
None listed